Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Best practices on advance notice of importation process for cosmetics and drugs The advance notice of importation process applies to the import of cosmetics and drugs, including natural health products (NHPs), that need to be modified or re-labelled to be sold legally in Canada.…
Annex 17, Parametric Release (PIC/S) - Guide to Good Manufacturing Practice for Medicinal Products Annexes Cover letter and PDF version 1. Principle 1.1 The definition of Parametric Release used in this Annex is based on that proposed by the European Organization for Quality: "A…
Annex 13 to the Good manufacturing practices guide for drugs used in clinical trials (GUI-0036): Overview Overview Guidance Glossary References Regulations referenced in this document Disclaimer: This document does not constitute part of the Food and Drugs Act (the Act) or its…
Annex 11 to the good manufacturing practices guide: Computerized Systems: GUI-0050 Download in PDF format (1.21 MB, 16 pages) Organization: Health Canada Published: August 10, 2021 Disclaimer This document does not constitute part of the Food and Drugs Act (the Act) or its…
Guidance Document Annex 4 to the Current Edition of the Good Manufacturing Practices Guidelines - Veterinary Drugs (GUI-0012) Overview Veterinary drugs Non-sterile, non-prescription veterinary drugs Veterinary drug premixes Definitions References Date issued: November 4, 2024…
Good manufacturing practices guidelines for active pharmaceutical ingredients (GUI-0104) - Summary Guidance on Drug Establishment Licences (GUI-0002) Guidance: How to demonstrate foreign building compliance with drug good manufacturing practices (GUI-0080) Risk classification…
Archived DEL and GMP temporary measures due to COVID-19 Health Canada has reviewed the good manufacturing practices and drug establishment licence temporary regulatory flexibilities we put in place during the pandemic. Our review process involves many considerations, including…
Regulations Regulations Amending the Food and Drug Regulations (1024 - Clinical Trials) Page details 2017-05-04
Good clinical practices: Guidance documents Guidance Document: Part C, Division 5 of the Food and Drug Regulations "Drugs for Clinical Trials Involving Human Subjects" (GUI-0100) Risk classification guide for observations related to inspections of clinical trials of human drugs…
Consultation on “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100: Guidance Document – Part C, Division 5 of the Food and Drug Regulations) From Health Canada Current status: Closed Between December 15th, 2017 and April 15th, 2018 Health Canada is seeking input from…
Page 4178 sur 6399Affichage de 41771 à 41780 sur 63986
Version préliminaire : la couverture est limitée au corpus actuel et les fonctionnalités peuvent changer.
